These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2452522)

  • 1. Potentiation of DNA damage and cytotoxicity by calmodulin antagonists.
    Rosenthal SA; Hait WN
    Yale J Biol Med; 1988; 61(1):39-49. PubMed ID: 2452522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced bleomycin-induced DNA damage and cytotoxicity with calmodulin antagonists.
    Lazo JS; Hait WN; Kennedy KA; Braun ID; Meandzija B
    Mol Pharmacol; 1985 Mar; 27(3):387-93. PubMed ID: 2579318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of bleomycin lethality by anticalmodulin drugs: a role for calmodulin in DNA repair.
    Chafouleas JG; Bolton WE; Means AR
    Science; 1984 Jun; 224(4655):1346-8. PubMed ID: 6203171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased growth inhibition and DNA lesions in human colon adenocarcinoma cells treated with methotrexate or 5-fluorodeoxyuridine followed by calmodulin inhibitors.
    Lönn U; Lönn S
    Cancer Res; 1988 Jun; 48(12):3319-23. PubMed ID: 2453268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calmodulin antagonist W 13 prevents DNA repair after bleomycin treatment of human urological tumor cells growing on extracellular matrix.
    Pavelić K
    Int J Biochem; 1987; 19(11):1091-5. PubMed ID: 2448175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lidocaine potentiation of bleomycin A2 cytotoxicity and DNA strand breakage in L1210 and human A-253 cells.
    Lazo JS; Braun ID; Meandzija B; Kennedy KA; Pham ET; Smaldone LF
    Cancer Res; 1985 May; 45(5):2103-9. PubMed ID: 2580616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxicity, calmodulin and DNA lesions in cells treated with streptozotocin.
    Lönn U; Lönn S
    Biochem Pharmacol; 1988 Sep; 37(18):3441-6. PubMed ID: 2971359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of sensitivity to bleomycin and the drug-induced DNA damage in EMT6 cells by the calmodulin inhibitor trifluoperazine.
    Smith PJ; Mircheva JJ; Bleehen NM
    Acta Physiol Pharmacol Bulg; 1987; 13(1):41-5. PubMed ID: 2441572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical modulation of bleomycin induced toxicity.
    Kennedy KA; Hait WN; Lazo JS
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1367-70. PubMed ID: 2428791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. W-7, a calmodulin inhibitor, potentiates dacarbazine cytotoxicity in human neoplastic cells.
    Lönn U; Lönn S
    Int J Cancer; 1987 May; 39(5):638-42. PubMed ID: 3570556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of bleomycin, hyperthermia and a calmodulin inhibitor (trifluoperazine) in mouse tumor cells.
    Smith PJ; Mircheva J; Bleehen NM
    Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1363-6. PubMed ID: 2428790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of bleomycin cytotoxicity in cultured mammalian cells by polyacrylic acid. III. Induction of DNA strand breakage and suppression of cellular heat production.
    Sarai K; Kohda K; Hayatsu H; Miyamae T; Kawazoe Y
    Anticancer Res; 1991; 11(2):957-60. PubMed ID: 1712183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of bleomycin A5 with calmodulin inhibitor on the proliferation of S-180 cells in vitro].
    Zhang HQ; He NG; Xue SB
    Zhongguo Yao Li Xue Bao; 1990 Sep; 11(5):470-3. PubMed ID: 1718143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of bleomycin, hyperthermia and a calmodulin inhibitor (trifluoperazine) in mouse tumour cells: II. DNA damage, repair and chromatin changes.
    Smith PJ; Mircheva J; Bleehen NM
    Br J Cancer; 1986 Jan; 53(1):105-14. PubMed ID: 2418859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting calmodulin for the development of novel cancer chemotherapeutic agents.
    Hait WN
    Anticancer Drug Des; 1987 Oct; 2(2):139-49. PubMed ID: 3329523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of bleomycin, hyperthermia and a calmodulin inhibitor (trifluoperazine) in mouse tumour cells: I. In vitro cytotoxicity.
    Mircheva J; Smith PJ; Bleehen NM
    Br J Cancer; 1986 Jan; 53(1):99-103. PubMed ID: 2418860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A calmodulin antagonist has no effect on the repair of X-ray-induced damage in a murine mammary carcinoma cell line.
    Ridinger DN; Loh SN; Warters RL; Dethlefsen LA
    Radiat Res; 1986 Nov; 108(2):127-38. PubMed ID: 3786673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between X-rays and SR 4233 for cytotoxicity and repair of potentially lethal damage in human cells.
    Biedermann KA; Brown JM
    Int J Radiat Biol; 1989 Nov; 56(5):813-6. PubMed ID: 2573680
    [No Abstract]   [Full Text] [Related]  

  • 19. Naringin, a grapefruit flavanone, protects V79 cells against the bleomycin-induced genotoxicity and decline in survival.
    Jagetia A; Jagetia GC; Jha S
    J Appl Toxicol; 2007; 27(2):122-32. PubMed ID: 17177233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased lethality of calmodulin antagonists and bleomycin to human bone marrow and bleomycin-resistant malignant cells.
    Lazo JS; Chen DL; Gallicchio VS; Hait WN
    Cancer Res; 1986 May; 46(5):2236-40. PubMed ID: 2421873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.